Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study): prospective cohort study in England

BACKGROUND: Long-term care facilities (LTCFs) have reported high SARS-CoV-2 infection rates and related mortality, but the proportion of infected people among those who have survived, and duration of the antibody response to natural infection, is unknown. We determined the prevalence and stability o...

Descripción completa

Detalles Bibliográficos
Autores principales: Krutikov, Maria, Palmer, Tom, Tut, Gokhan, Fuller, Christopher, Azmi, Borscha, Giddings, Rebecca, Shrotri, Madhumita, Kaur, Nayandeep, Sylla, Panagiota, Lancaster, Tara, Irwin-Singer, Aidan, Hayward, Andrew, Moss, Paul, Copas, Andrew, Shallcross, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8676418/
https://www.ncbi.nlm.nih.gov/pubmed/34935001
http://dx.doi.org/10.1016/S2666-7568(21)00282-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8676418/
https://www.ncbi.nlm.nih.gov/pubmed/34935001
http://dx.doi.org/10.1016/S2666-7568(21)00282-8

Ejemplares similares